Real Experts. Real Trades. Real Profits
Yesterday was my first day back full-time, since Monday last week, and it was an eventful one! It was great to be back in the chatroom with my members, discussing and sharing ideas and trading live. One such idea that I shared with my members yesterday was an...
I hope you all had a wonderful Thanksgiving and holiday. As you know, I was mainly out last week due to the holiday; however, I am back this morning! As we begin a new week, I think many biotech bulls will quickly want to forget last week! I say this, of course,...
When it comes to the markets and trading, I am sure of one thing: the markets are forever evolving. There's no better way to put it than this old saying: "adapt or die." I have recently picked up on a few adjustments that could be implemented to remain relevant...
This is just a friendly reminder for my members that I will be on vacation from today until next Monday, but don't worry, I won't leave you hanging! I'll still be sharing ideas and case studies for the Penny Pro and Biotech Breakouts while I am away! But before I...
Happy Monday! Just a friendly reminder for my members that I will be on vacation from tomorrow until next week, but don’t worry, I won’t leave you hanging! I’ll still be sharing ideas and case studies for the Penny Pro and Biotech Breakouts while I am away. Last...
I asked everyone if they were excited about my Mission to Million. Feedback FLOODED in! I guess that’s what you can expect when a 20+ year pro trader launches the most significant journey of his career. This isn’t some “take the money and run” gimmick. I’m here for...
Good day, 360! Here are some of our top movers today. And don’t forget to join us for Mission to Million 🚀- happening 1pm EST. Get excited about our brand new member trading challenge (revealed today!). Please register here. FOCUS LIST🔎 VSTE – Up over 90%...
As we dive into the world of medical technology, one company that’s caught my attention is Bioventus (BVS). This Durham-based firm has been making waves in the industry with its innovative orthobiologic products for treating musculoskeletal conditions. And...
In a major breakthrough for the medical community, Mineralys Therapeutics has announced positive topline results from its pivotal Launch-HTN and Advance-HTN trials evaluating the efficacy and safety of lorundrostat for treating uncontrolled hypertension (uHTN) or...
In a move that’s sending shockwaves through the real estate industry, Redfin (RDFN) has announced it will be acquired by Rocket Companies in an all-stock deal worth $1.75 billion. The acquisition values Redfin at $12.50 per share, representing a whopping 63%...